The Medicines Company to Participate in 33rd Annual J.P. Morgan Healthcare Conference

05 Jan 2015

The Medicines Company (NASDAQ:MDCO) is scheduled to present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 12th at 7:30 AM PST / 10:30 AM EST.

The session will be webcast with a link available at The Medicines Company’s website http://www.themedicinescompany.com.

About The Medicines Company

The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: serious infectious disease care, acute cardiovascular care and surgery and perioperative care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.


Contacts

Investor Relations:
The Medicines Company
Neera Dahiya Ravindran, MD, +1 (973) 290-6044
Vice President, Investor Relations & Strategic Planning
neera.ravindran@themedco.com
or
Media:
Bob Laverty, +1-973-290-6162
Vice President, Communications
Office of D.E.S.I.GN
robert.laverty@themedco.com

Contact Us

The Medicines Company
8 Sylvan Way
Parsippany, NJ 07054 USA
Tel 973 290 6000
Toll-free 800 388 1183
Global Medical Information

Human Resources
Verification of employment
Tel 973 290 6361
Fax 862 207 6361

Investors Relations

Krishna Gorti, MD
Tel 973 290 6122
krishna.gorti@themedco.com

Media Inquiries

Michael Blash
Tel 973 290 6100
michael.blash@themedco.com